修订版心脏风险指数、个体危险因素及其持续时间对初次全膝关节置换术后主要不良心脏事件的影响:全国性倾向匹配队列研究
该回顾性队列研究基于全国性索赔数据库纳入2017至2021年初次全膝关节置换术患者,按修订版心脏风险指数(RCRI)评分进行倾向评分匹配后分析术后30天、90天及1年主要不良心脏事件(MACE)。匹配后72,672例患者中,MACE发生率分别为0.18%、0.40%和1.43%,RCRI≥2者各时期风险约翻倍,中重度肾功能不全为最一致预测因子,RCRI≥2且年龄≥75岁者30天风险增高。
要点
- RCRI评分可预测全膝关节置换术后MACE风险,RCRI≥2者各时期风险约翻倍。
- 中重度肾功能不全为最一致预测因子,术前≤1年诊断者风险尤为显著。
- RCRI≥2且年龄≥75岁者30天MACE风险增高,需加强围手术期监测。
核心结论
- RCRI对全膝关节置换术后MACE具有预测效度,危险因素持续时间与年龄分层可提供增量预后价值。
- 近期中重度肾功能不全且年龄≥75岁合并RCRI≥2的患者需更密切的围手术期监测。
研究设计与样本
- 回顾性队列研究,使用全国性索赔数据库,纳入2017至2021年初次全膝关节置换术患者。
- 按RCRI评分(0、1、≥2)进行倾向评分匹配,匹配后共72,672例患者。
- RCRI针对索赔数据修订,肾功能不全定义为慢性肾脏病≥3期。
- 危险因素按术前持续时间分类:无、≤1年、>1年。
- 主要结局为30天、90天及1年MACE,采用分层Cox模型估计调整风险比(aHR)。
主要发现
- 匹配后72,672例患者中,MACE发生率在30天、90天和1年分别为0.18%、0.40%和1.43%。
- 与RCRI 0相比,RCRI 1增加术后1年风险(aHR 1.34,P < 0.001)。
- RCRI≥2在各时期风险约翻倍(aHR 1.86至2.15,所有P值≤0.003)。
- 中重度肾功能不全为最一致预测因子(所有P值≤0.001),术前≤1年诊断者尤为显著。
- RCRI≥2患者中,年龄≥75岁增加30天MACE风险(aHR 2.27,P = 0.004),而<75岁者风险在90天时显著(P < 0.001)。
关键数值与推荐
- RCRI评分0、1、≥2对应的术后1年MACE风险分别为参照、aHR 1.34(P < 0.001)、aHR 1.86至2.15(所有P值≤0.003)。
- 中重度肾功能不全预测MACE的所有P值≤0.001,术前≤1年诊断者风险更为显著。
- RCRI≥2且年龄≥75岁者30天MACE风险aHR 2.27(P = 0.004),<75岁者90天风险P < 0.001。
临床怎么用
- 术前可采用RCRI评分评估全膝关节置换术后MACE风险,RCRI≥2者风险约翻倍。
- 应关注危险因素持续时间,尤其是术前≤1年的中重度肾功能不全。
- RCRI≥2且年龄≥75岁患者需加强围手术期心脏监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although the Revised Cardiac Risk Index (RCRI) is widely used to assess major adverse cardiac events (MACE) preoperatively, the impact of risk-factor duration and age stratification on its predictive performance after total knee arthroplasty (TKA) remains unclear. This study evaluated post-TKA MACE incidence and risk according to RCRI score, individual risk factors, their preoperative duration, and age strata. METHODS: This retrospective cohort study used a nationwide claims database, including primary TKA patients (2017 to 2021). The RCRI was modified for claims data by defining renal impairment as chronic kidney disease stage ≥ 3. Following propensity-score matching by RCRI scores (0, 1, ≥ 2), risk factors were categorized by preoperative duration: absent, ≤ one year, or greater than one year. The primary outcomes were 30-day, 90-day, and 1-year MACE. Adjusted hazard ratios (aHRs) were estimated using stratified Cox models. RESULTS: Among 72,672 matched patients, MACE incidence was 0.18, 0.40, and 1.43% at 30 days, 90 days, and one year, respectively. The MACE risk increased with the RCRI category; versus RCRI 0, RCRI 1 raised the postoperative 1-year risk (aHR 1.34, P < 0.001), whereas RCRI ≥ 2 roughly doubled the risk across all periods (aHR 1.86 to 2.15, all P-values ≤ 0.003). Moderate-to-severe renal impairment was the most consistent predictor (all P-values ≤ 0.001), especially when diagnosed ≤ one year preoperatively. Among RCRI ≥ 2 patients, age ≥ 75 years increased 30-day MACE risk (aHR 2.27, P = 0.004), whereas risk in those aged less than 75 years became significant at 90 days (P < 0.001). CONCLUSION: The RCRI provides predictive validity for post-TKA MACE. Beyond static scores, risk-factor duration and age stratification offer incremental prognostic value. Patients who had recent moderate-to-severe renal impairment and older age (≥ 75 years) combined with RCRI ≥ 2 warrant closer perioperative monitoring.
引用
- Chiang LY, Chu YR, Kung PT, et al. Impact of Revised Cardiac Risk Index, Individual Risk Factors, and Their Duration on Major Adverse Cardiac Events After Primary Total Knee Arthroplasty: A Nationwide Propensity-Matched Cohort Study. J Arthroplasty. 2026. PMID: 42843682. doi:10.1016/j.arth.2026.09.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。